However, analyzing publicly available DNA microarray data of 1656 ovarian cancer patients revealed a lower chemerin expression in ovarian cancer tissue than in normal ovary (p = 0.018), and using the Kaplan–Meier plotter software revealed that high chemerin expression negatively affected both OS (p = 5.8 × 10−5) and progression-free survival (PFS; p = 0.00024) of ovarian cancer patients [64,71]. The gene discussed is RARRES2; the disease is ovarian cancer.